Research Publications

Click the > symbol to read a summary of the publication.

Rollman TB, Berkebile ZW, Hicks DM, Hatfield JS, Chauhan P, Pravetoni M, Schleiss MR, Milligan GN, Morgan TK, Bierle CJ. CD4+ but not CD8+ T cells are required for protection against severe guinea pig cytomegalovirus infections. PLoS Pathog. 2024 Nov 4;20(11):e1012515. doi: 10.1371/journal.ppat.1012515. eCollection 2024 Nov.

Liu BM, Hayes AW. Mechanisms and Assessment of Genotoxicity of Metallic Engineered Nanomaterials in the Human Environment. Biomedicines. 2024 Oct 20;12(10):2401. doi: 10.3390/biomedicines12102401.

Liu BM. Epidemiological and clinical overview of the 2024 Oropouche virus disease outbreaks, an emerging/re-emerging neurotropic arboviral disease and global public health threat. J Med Virol. 2024 Sep;96(9):e29897. doi: 10.1002/jmv.29897.

Seasely AR, Blanchard CT, Arora N, Battarbee AN, Casey BM, Dionne-Odom J, Leal SM Jr, Moates DB, Sinkey RG, Szychowski JM, Tita AT, Subramaniam A; CWRH's COVID-19 Working Group;. Maternal and Perinatal Outcomes Associated With the Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection. Obstet Gyneco. 2022 Aug 1;140(2):262-265. doi: 10.1097/AOG.0000000000004849. Epub 2022 May 18. PMID: 35852277.

Seasely AR, Blanchard CT, Arora N, Battarbee AN, Casey BM, Dionne-Odom J, Leal SM Jr, Moates DB, Sinkey RG, Szychowski JM, Tita AT, Subramaniam A; CWRH COVID-19 Working Group. Maternal and Perinatal Outcomes Associated With the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Delta (B.1.617.2) Variant. Obstet Gynecol. 2021 Dec 1;138(6):842-844. doi: 10.1097/AOG.0000000000004607. PMID: 34592747.